UK markets closed
  • FTSE 100

    7,009.56
    -143.87 (-2.01%)
     
  • FTSE 250

    22,304.69
    -230.45 (-1.02%)
     
  • AIM

    1,229.94
    -11.43 (-0.92%)
     
  • GBP/EUR

    1.1639
    -0.0050 (-0.43%)
     
  • GBP/USD

    1.3816
    -0.0108 (-0.78%)
     
  • BTC-GBP

    26,488.93
    -1,885.38 (-6.64%)
     
  • CMC Crypto 200

    903.27
    -36.67 (-3.90%)
     
  • S&P 500

    4,183.03
    -38.83 (-0.92%)
     
  • DOW

    33,442.63
    -380.82 (-1.13%)
     
  • CRUDE OIL

    71.91
    +0.87 (+1.22%)
     
  • GOLD FUTURES

    1,778.10
    +3.30 (+0.19%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,434.07
    -293.60 (-1.87%)
     
  • CAC 40

    6,565.21
    -101.05 (-1.52%)
     

Global Smart Insulin Pens and Pumps Market to Reach $5.2 Billion by 2027

·13-min read

Abstract: - Global Smart Insulin Pens and Pumps Market to Reach $5. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Smart Insulin Pens and Pumps estimated at US$2.

New York, June 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Smart Insulin Pens and Pumps Industry" - https://www.reportlinker.com/p06032909/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at aCAGR of 8.6% over the period 2020-2027. Pumps, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$4.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pens segment is readjusted to a revised 12.5% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $868.3 Million, While China is Forecast to Grow at 8% CAGR
- The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$868.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$908.9 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

- Select Competitors (Total 35 Featured) -

  • Cellenovo

  • Companion Medical Inc.

  • Emperra Gmbh E-Health Technologies

  • F Hoffmann-La Roche

  • Insulet Corporation

  • Jiangasu Delfu Medical Device Co Ltd

  • Medical Inc.

  • Medtronic Inc.

  • Novo Nordisk

  • Sooil Development

  • Tandem Diabetes Care

  • Valeritas Inc.

  • Ypsomed




Read the full report: https://www.reportlinker.com/p06032909/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Smart Insulin Pens
and Pumps by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World 7-Year Perspective for Smart Insulin Pens and
Pumps by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Pumps by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 4: World 7-Year Perspective for Pumps by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 5: World Current & Future Analysis for Pens by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for Pens by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World for Years 2020 &
2027

Table 7: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World 7-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Home Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 10: World 7-Year Perspective for Home Care by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 11: World Current & Future Analysis for Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 12: World 7-Year Perspective for Laboratories by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 13: USA Current & Future Analysis for Smart Insulin Pens
and Pumps by Product - Pumps and Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 14: USA 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 15: USA Current & Future Analysis for Smart Insulin Pens
and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 16: USA 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

CANADA
Table 17: Canada Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 18: Canada 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 19: Canada Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 20: Canada 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

JAPAN
Table 21: Japan Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 22: Japan 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 23: Japan Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 24: Japan 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

CHINA
Table 25: China Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 26: China 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 27: China Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 28: China 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

EUROPE
Table 29: Europe Current & Future Analysis for Smart Insulin
Pens and Pumps by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 30: Europe 7-Year Perspective for Smart Insulin Pens and
Pumps by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2020 & 2027

Table 31: Europe Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 32: Europe 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 33: Europe Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 34: Europe 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

FRANCE
Table 35: France Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 36: France 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 37: France Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: France 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

GERMANY
Table 39: Germany Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 40: Germany 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 41: Germany Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Germany 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

ITALY
Table 43: Italy Current & Future Analysis for Smart Insulin
Pens and Pumps by Product - Pumps and Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 44: Italy 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 45: Italy Current & Future Analysis for Smart Insulin
Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 46: Italy 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

UNITED KINGDOM
Table 47: UK Current & Future Analysis for Smart Insulin Pens
and Pumps by Product - Pumps and Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 48: UK 7-Year Perspective for Smart Insulin Pens and
Pumps by Product - Percentage Breakdown of Value Sales for
Pumps and Pens for the Years 2020 & 2027

Table 49: UK Current & Future Analysis for Smart Insulin Pens
and Pumps by End-Use - Hospitals & Clinics, Home Care and
Laboratories - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: UK 7-Year Perspective for Smart Insulin Pens and
Pumps by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Laboratories for the Years
2020 & 2027

REST OF EUROPE
Table 51: Rest of Europe Current & Future Analysis for Smart
Insulin Pens and Pumps by Product - Pumps and Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 52: Rest of Europe 7-Year Perspective for Smart Insulin
Pens and Pumps by Product - Percentage Breakdown of Value Sales
for Pumps and Pens for the Years 2020 & 2027

Table 53: Rest of Europe Current & Future Analysis for Smart
Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home
Care and Laboratories - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 54: Rest of Europe 7-Year Perspective for Smart Insulin
Pens and Pumps by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care and Laboratories for the
Years 2020 & 2027

ASIA-PACIFIC
Table 55: Asia-Pacific Current & Future Analysis for Smart
Insulin Pens and Pumps by Product - Pumps and Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Asia-Pacific 7-Year Perspective for Smart Insulin
Pens and Pumps by Product - Percentage Breakdown of Value Sales
for Pumps and Pens for the Years 2020 & 2027

Table 57: Asia-Pacific Current & Future Analysis for Smart
Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home
Care and Laboratories - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 58: Asia-Pacific 7-Year Perspective for Smart Insulin
Pens and Pumps by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care and Laboratories for the
Years 2020 & 2027

REST OF WORLD
Table 59: Rest of World Current & Future Analysis for Smart
Insulin Pens and Pumps by Product - Pumps and Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 60: Rest of World 7-Year Perspective for Smart Insulin
Pens and Pumps by Product - Percentage Breakdown of Value Sales
for Pumps and Pens for the Years 2020 & 2027

Table 61: Rest of World Current & Future Analysis for Smart
Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home
Care and Laboratories - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: Rest of World 7-Year Perspective for Smart Insulin
Pens and Pumps by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care and Laboratories for the
Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 35
Read the full report: https://www.reportlinker.com/p06032909/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting